Aquinox Pharmaceuticals

Aquinox Pharmaceuticals

Signal active

Organization

Contact Information

Overview

Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

About

Industries

Biotechnology, Health Care, Therapeutics

Founded

2004

Employees

11-50

Headquarters locations

North America

Social

N/A

Profile Resume

Aquinox Pharmaceuticals headquartered in North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $21.3B in funding across 96 round(s). With a team of 11-50 employees, Aquinox Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Aquinox Pharmaceuticals, raised $25.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Thomas MacRury

Thomas MacRury

EVP & Chief Operating Officer

imagePlace Stephen Majlath

Stephen Majlath

Director, Finance

Funding Rounds

Funding rounds

8

Investors

5

Lead Investors

0

Total Funding Amount

$221.4M

Details

3

Aquinox Pharmaceuticals has raised a total of $221.4M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2007Early Stage Venture14.5M
2013Late Stage Venture18.0M
2010Early Stage Venture25.0M

Investors

Aquinox Pharmaceuticals is funded by 30 investors.

Investor NameLead InvestorFunding RoundPartners
Elaine Jones-FUNDING ROUND - Elaine Jones25.0M
Pfizer Venture Investments-FUNDING ROUND - Pfizer Venture Investments25.0M
Aquinox Pharmaceuticals-FUNDING ROUND - Aquinox Pharmaceuticals25.0M
BC Advantage Funds-FUNDING ROUND - BC Advantage Funds25.0M

Recent Activity

There is no recent news or activity for this profile.